End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.86 CNY | +5.67% | +3.27% | -9.93% |
04-26 | Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-19 | Yixintang Pharmaceutical's Profit Falls 46% as Revenue Stays Nearly Flat | MT |
Evolution of the average Target Price on Yixintang Pharmaceutical Group Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Yixintang Pharmaceutical Group Co., Ltd.
UBS |
EPS Revisions
- Stock Market
- Equities
- 002727 Stock
- Consensus Yixintang Pharmaceutical Group Co., Ltd.